BHC insiders

20 insiders have filed at BHC since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.

namerolereported stake% of companybuys (3y)sells (3y)
Paulson JohnDirector73.62M19.747%8 buys $369.6M
Paulson & Co. Inc.10% owner73.26M19.65%1 buys $15.6M
Appio ThomasChief Executive Officer2.32M0.621%
Charhon Jean-JacquesEVP, CFO706.5k0.19%
Carson SeanaEVP, General Counsel616.8k0.165%13 sells $419k
Vadaketh Tom GeorgeEVP, Chief Financial Officer564.9k0.152%
Lenar Aimee J.EVP, Us Pharma400.3k0.107%
Wechsler Amy BDirector266.4k0.071%
Power Robert NDirector254.7k0.068%
Miller Steven DDirector239.2k0.064%
Kavanagh Sarah BDirector236.4k0.063%
Robertson Russel CDirector225.3k0.06%
Icahn BrettDirector220.3k0.059%
Barresi John SSVP, Controller & CAO192.3k0.052%
Mulligan RichardDirector155.6k0.042%
Garcia Christian ADirector89.7k0.024%
Lee Frank D.Director73.8k0.02%1 sells $122k
Lee Steven HyosigSVP, Controller & CAO73.2k0.02%
Leung SandraDirector38.4k0.01%
Goettler MichaelDirector30.1k<0.01%

Full register at boothcheck.com/insiders/BHC. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.

BHC institutional holders · BHC research report